Search

everythinglearnresearchcommunity

for

Search:↓

A new gene, JMJD1C, may affect testosterone levels in men.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Vitamin D levels do not significantly relate to the causes of PCOS or DOR in infertile patients.

Treatment during development affects hormone balance and sexual behavior in male rats.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

No significant link between hair loss and iron or thyroid levels was found, but checking for deficiencies might still be useful.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Certain gene variations increase male hair loss risk, influenced by hormone levels.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

High androgen levels and genetic factors likely cause Becker's nevus and related symptoms.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.